DC Field | Value | Language |
dc.contributor.author | Clark, David | - |
dc.contributor.author | Klee, Harry | - |
dc.contributor.author | Dandekar, Abhaya | - |
dc.date.accessioned | 2018-11-06T02:20:09Z | - |
dc.date.available | 2018-11-06T02:20:09Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | http://lrc.quangbinhuni.edu.vn:8181/dspace/handle/DHQB_123456789/4145 | - |
dc.description | The acreage of agronomic crops
(soybean, cotton, corn and canola)
developed using recombinant DNA
technology has expanded dramatically
since their introduction in 1996,
while the commercialization of biotech
horticultural crops (vegetables,
fruits, nuts and ornamentals) has
languished. This is not due to a lack
of both current and potential traits
that could be utilized in horticultural
crops, as ongoing research is identifying
a diverse array of applications.
However, commercialization is stalled
by market reluctance to accept biotech
products, particularly in the absence
of clear benefits to consumers.
High regulatory costs and restricted
access to intellectual property create
additional hurdles for specialty crops.
These challenges are causing the horticultural
industry to forego a number
of current benefits. New products
with clear advantages for producers,
marketers and consumers may be
required before the potential of biotechnology
can be realized. | vi |
dc.language.iso | en | vi |
dc.publisher | CALIFORNIA AGRICULTURE | vi |
dc.relation.ispartofseries | ;VOLUME 58, NUMBER 2 | - |
dc.subject | Agriculture | vi |
dc.subject | transgenic horticultural | vi |
dc.title | Despite benefits, commercialization of transgenic horticultural crops lags | vi |
dc.type | Article | vi |
Appears in Collections: | Các chuyên ngành khác
|